t researchers focus their research on erradicating the hbv
template cccDNA, which keeps the viral infection going, instead of focussing on the by-products of the virus? to me it feels the big drug companies are not interested in finding a finite treatment or cure for hbv, because that would mean no more sustained flow of capital to their coffers.